Patents by Inventor REGIS GABRIEL STENTZ

REGIS GABRIEL STENTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERING GUT COMMENSAL BACTERIA TO EXPRESS HETEROLOGOUS PROTEINS IN THEIR OUTER MEMBRANE VESICLES (OMVS) FOR DELIVERY TO THE GI-TRACT
    Publication number: 20210268094
    Abstract: This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 2, 2021
    Applicants: QUADRAM INSTITUTE BIOSCIENCE, UEA ENTERPRISES LIMITED
    Inventors: REGIS GABRIEL STENTZ, SIMON RICHARD CARDING
  • Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract
    Patent number: 11000581
    Abstract: This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: May 11, 2021
    Assignees: QUADRAM INSTITUTE BIOSCIENCE, UEA ENTERPRISES LIMITED
    Inventors: Regis Gabriel Stentz, Simon Richard Carding
  • ENGINEERING GUT COMMENSAL BACTERIA TO EXPRESS HETEROLOGOUS PROTEINS IN THEIR OUTER MEMBRANE VESICLES (OMVS) FOR DELIVERY TO THE GI-TRACT
    Publication number: 20190099477
    Abstract: This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant bacteria capable of producing such vesicles, and methods for the production of such vesicles. The invention further relates to an inducible expression system for use in recombinant bacteria.
    Type: Application
    Filed: April 28, 2017
    Publication date: April 4, 2019
    Inventors: REGIS GABRIEL STENTZ, SIMON RICHARD CARDING